An interventional study of REACH in Asthma (Diagnosis), sponsored by Washington University School of Medicine. Recruiting at 1 site in United States. Open to participants aged 3 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-09-21.
Sponsored by Washington University School of Medicine · Not applicable, Interventional, and Health services research
Among 13 studies in Asthma by Washington University School of Medicine — 2 open to participants now, 3 under way, none of them phase 3. Asthma · Washington University School of Medicine.
Among the 13 studies in Asthma by Washington University School of Medicine, this one is the 3rd largest by planned enrollment of the 11 interventional ones, is one of 2 that started in 2026, is one of 5 with no phase, and was the 13th registered.
4,841 studies on the registry are indexed under Asthma; 600 are open to participants now.
This study's planned enrollment of 430 is above the median of 78 across 3,341 interventional studies indexed under Asthma.
Browse Asthma studies →2 of the 13 studies in Asthma by Washington University School of Medicine are open now, in 1 country. Each count lists the studies.
Of the 417 Asthma studies recruiting now, 140 (34%) set no upper age limit and 205 (49%) stop at 75 or younger; 146 take children under 18; 104 take healthy volunteers.
This study: 3 Years to 18 Years · all sexes · no healthy volunteers.
The full table on the hub →13 studies; the count open now beside each. This study's row is marked.
First in 1997; this study’s year is marked. 2 started in 2026.
Median enrollment 191 across the 11 interventional studies, 127 across the 2 observational. Of the 10 that completed or were terminated, 1 (10%) have results posted.
Washington University School of Medicine is the lead sponsor of 1,803 studies on the registry; 271 are open to participants now.
Of its 329 completed or terminated interventional studies of FDA-regulated products, 216 (66%) have results posted.
2 of the studies in Asthma by Washington University School of Medicine that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05111262Washington University School of MedicineSymptom-driven ICS/LABA Therapy for Patients With Asthma Non-adherent to Daily Maintenance Inhalers | 2027-09-30 |
| NCT07241117Washington University School of MedicineCHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma | 2027-11-15 |
Among the 13 studies in Asthma by Washington University School of Medicine, from their registry updates:
Nothing recorded among them since 2026-09-25.
This study pilots REACH, Resources and Education for Addressing Chronic Health, a service model to facilitate care coordination and communication across medical, school, and home settings. REACH seeks to address barriers to school-based asthma management, improving health and educational outcomes and reducing negative impacts for children with asthma.
This study develops and tests the REACH intervention which includes (a) a strategic communication or messaging and dissemination strategy to build school and family relationships and trust, (b) capacity building activities to improve asthma knowledge and awareness through asthma education and resources, and (c) a tool/hub that allows record and communication sharing across healthcare and educational systems to facilitate care coordination. Using a Single-Arm Non-Randomized Pre-Post Cluster Trial design, this study tests the hypothesis that use of a care coordination hub will improve school-based asthma management.
Parents (N=200)/Children (N=200)
Inclusion criteria for recruited parents/children:
Exclusion Criteria for recruited families:
School Nurses (Implementers) (N=15)
Inclusion Criteria for school nurses:
Exclusion Criteria for school nurses:
- Do not work for partner school district or for an identified building
Providers (N =15)
Inclusion Criteria for Providers:
- Provide care to a child participant on the study
Exclusion Criteria for Providers:
- Do not provide care to a child participant on the study
Consists of school nurses who serve as both participants and REACH intervention implementers, students and their caregivers, and student providers. Though there are several participant types, there is only 1 experimental group. All participants serve as their own controls.
Other: REACH
The REACH intervention which includes (a) a strategic communication or messaging and dissemination strategy to build school and family relationships and trust, (b) capacity building activities to improve asthma knowledge and awareness through asthma education and resource provided both digitally and in-person, and (c) a tool or dashboard that allows records and communication sharing across healthcare and educational systems to facilitate care coordination (REACH tool).
Asthma knowledge and awareness
Measured via survey. Data collected from student caregivers and school nurse implementers.
Time frame: Measured at baseline and at study completion (average of 1 year)
Implementation
Measured via surveys and post-trial semi-structured focus group/interview. Data collected from student caregivers, school nurse implementers, and providers.
Time frame: Measured at trial mid-point (approximately 6 months following enrollment) for school nurses only, and at study completion (average of 1 year) for all noted groups
Asthma guideline adherence
Measured via survey. Data collected from student caregivers and school nurse implementers.
Time frame: Measured at baseline and at study completion (average of 1 year)
School connectedness
Measured via survey. Data collected from student caregivers.
Time frame: Measured at baseline and at study completion (average of 1 year)
Healthcare utilization
Number of asthma related emergency department visits, hospitalizations, and clinic/office visits collected from the electronic medical record.
Time frame: 24 months prior to intervention, during intervention, and 12 months following intervention completion
School Attendance/Absence
Number of days student is attends school, and number of school absence days. Data provided by the school.
Time frame: 24 months prior to intervention, during intervention, and 12 months following intervention completion
Plan to share: Yes — all IPD that underlie results in a publication
Supporting information: Study protocol, Statistical analysis plan
Time frame: Beginning 1 year after publication with no end date.
Access criteria: Any researcher may request access with a description of the planned use and analyses, and a completed and approved data sharing agreement.
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Washington University School of Medicine →